Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Vaccination for Prevention of Postoperative Pulmonary Infection in Lung Resection Patients
NCT07885540Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Nov 2026
- Primary completion
- Apr 2028
01
Overview
A Phase 4 trial of 23-valent pneumococcal polysaccharide vaccine, quadrivalent split-virion influenza vaccine in postoperative pneumonia, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
23-valent pneumococcal polysaccharide vaccinequadrivalent split-virion influenza vaccine
03
Conditions
postoperative pneumonia
Beyond the preview
Go deeper on NCT07885540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07885540.